Legacy has announced $7.5 million in new funding from TRAC, Samsung Next Ventures, and others, including new and existing investors like FirstMark, bringing its total raised to over $45 million, per Business Insider.

Founded in 2019, Legacy provides sperm testing and freezing, facilitated by at-home kits shipped to patients’ doors, and has processed 25,000 sperm samples to date.

Male fertility has been on the decline for decades and the average sperm count has halved in the last fifty years. Yet while several companies have notched billion-dollar valuations to provide fertility care to women, the male fertility market hasn’t seen the same boom. Legacy Founder Khaled Kteily wants to change that.

“Our prediction has always been that within five years from now, sperm freezing will be as normal for someone to talk about as egg freezing is today,” he told Business Insider’s Rebecca Torrence.